These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19209017)

  • 1. Efficacy and toxicity of 153samarium-EDTMP in painful breast cancer bone metastases.
    Dolezal J
    Onkologie; 2009 Feb; 32(1-2):35-9. PubMed ID: 19209017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of samarium-153-EDTMP radionuclide treatment for bone metastases in patients with hormone-refractory prostate cancer.
    Dolezal J; Vizda J; Odrazka K
    Urol Int; 2007; 78(1):50-7. PubMed ID: 17192733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myelotoxicity after systemic radionuclide therapy of painful bone metastases with 153Samarium-EDTMP ].
    Dolezal J; Vizd'a J; Cermáková E
    Vnitr Lek; 2003 Mar; 49(3):189-93. PubMed ID: 12728593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases.
    Thapa P; Nikam D; Das T; Sonawane G; Agarwal JP; Basu S
    J Nucl Med; 2015 Oct; 56(10):1513-9. PubMed ID: 26315829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma.
    Baczyk M; Czepczyński R; Milecki P; Pisarek M; Oleksa R; Sowiński J
    Nucl Med Commun; 2007 Apr; 28(4):245-50. PubMed ID: 17325585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical role of Sm-153 EDTMP in the treatment of painful bone metastatic disease.
    Coronado M; Redondo A; Coya J; Espinosa E; Couto RM; Zamora P; Marin MD; Castelo B; Lillo ME; Frutos L; Barón MG; Curto LM
    Clin Nucl Med; 2006 Oct; 31(10):605-10. PubMed ID: 16985364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of 177Lu-EDTMP in bone metastatic pain palliation in breast cancer and hormone refractory prostate cancer: a phase II study.
    Yuan J; Liu C; Liu X; Wang Y; Kuai D; Zhang G; Zaknun JJ
    Clin Nucl Med; 2013 Feb; 38(2):88-92. PubMed ID: 23334120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 153Sm-EDTMP for bone pain palliation in skeletal metastases.
    Maini CL; Bergomi S; Romano L; Sciuto R
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S171-8. PubMed ID: 15127241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (153)Sm-EDTMP for pain relief of bone metastases from prostate and breast cancer and other malignancies.
    Correa-González L; Arteaga de Murphy C; Pichardo-Romero P; Pedraza-López M; Moreno-García C; Correa-Hernández L
    Arch Med Res; 2014 May; 45(4):301-8. PubMed ID: 24681187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
    Anderson PM; Wiseman GA; Dispenzieri A; Arndt CA; Hartmann LC; Smithson WA; Mullan BP; Bruland OS
    J Clin Oncol; 2002 Jan; 20(1):189-96. PubMed ID: 11773169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (177)Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study.
    Agarwal KK; Singla S; Arora G; Bal C
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):79-88. PubMed ID: 25070686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.
    Liepe K; Kotzerke J
    Nucl Med Commun; 2007 Aug; 28(8):623-30. PubMed ID: 17625384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain.
    Liepe K; Runge R; Kotzerke J
    J Cancer Res Clin Oncol; 2005 Jan; 131(1):60-6. PubMed ID: 15449184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ¹⁷⁷Lu-EDTMP for treatment of bone pain in patients with disseminated skeletal metastases.
    Shinto AS; Shibu D; Kamaleshwaran KK; Das T; Chakraborty S; Banerjee S; Thirumalaisamy P; Das P; Veersekar G
    J Nucl Med Technol; 2014 Mar; 42(1):55-61. PubMed ID: 24503346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the dose-myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMP.
    Pacilio M; Ventroni G; Basile C; Ialongo P; Becci D; Mango L
    Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):238-52. PubMed ID: 24077786
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Alavi M; Khajeh-Rahimi F; Yousefnia H; Mohammadianpanah M; Zolghadri S; Bahrami-Samani A; Ghannadi-Maragheh M
    Cancer Biother Radiopharm; 2019 Jun; 34(5):280-287. PubMed ID: 30977670
    [No Abstract]   [Full Text] [Related]  

  • 17. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial.
    Serafini AN; Houston SJ; Resche I; Quick DP; Grund FM; Ell PJ; Bertrand A; Ahmann FR; Orihuela E; Reid RH; Lerski RA; Collier BD; McKillop JH; Purnell GL; Pecking AP; Thomas FD; Harrison KA
    J Clin Oncol; 1998 Apr; 16(4):1574-81. PubMed ID: 9552068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Our experience on pain palliation of bone metastasis with Sr-89 or Sm-153 in cancer patients resistant to a conventional analgesic therapy. A retrospective study.
    Montesano T; Giacomobono S; Acqualagna G; Colandrea M; Di Nicola A; Travascio L; Giancamerla M; D'Apollo R; Toteda M; Ugolini F; Filesi M; Ronga G
    Clin Ter; 2009; 160(3):193-9. PubMed ID: 19756320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of efficacy of 153Sm-EDTMP in patients with painful bone metastases of breast cancer].
    Wu H; Tan T; Fang L; Zhang X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):716-8. PubMed ID: 14619591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Background, reasons and benefits using the vienna protocol for the treatment of painful bone recurrences with 153Samarium-EDTMP.
    Sinzinger H; Weiss K; Hiltunen J
    Anticancer Res; 2009 Aug; 29(8):3393-5. PubMed ID: 19661362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.